Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Jeanie Herbert - Head, Investor Relations & Corporate Communications Mark Foley - President & Chief Executive Officer Dustin Sjuts - Chief Commercial Officer, Aesthetics & Therapeutics Toby Schilke - Chief Financial Officer Abhay Joshi - Chief Operating Officer & President of R&D & Product Operations Conference Call Participants Terence Flynn - Goldman Sachs Stacy Ku - Cowen & Company Dav ...